This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Altria (MO) Poised on Solid Pricing, Growth in Low Risk Products
by Zacks Equity Research
Altria (MO) gains from rising popularity of IQOS and oral tobacco offerings. Moreover, pricing power is supporting revenue growth.
Phillip Morris (PM) Poised for Growth on RRPs & Strong Pricing
by Zacks Equity Research
Philip Morris' (PM) strong offerings in the reduced risk products space and solid pricing of combustible products are driving growth.
Will Staples ETFs Shine on Philip Morris (PM) Q4 Earnings Beat?
by Sweta Jaiswal, FRM
Philip Morris (PM) delivers better-than-expected earnings results amid the coronavirus crisis.
Energizer (ENR) Q1 Earnings Top Estimates, Revenues Up Y/Y
by Zacks Equity Research
Energizer's (ENR) first-quarter fiscal 2021 results reflect gains from strong demand for batteries, lights and auto care.
Is Philip Morris International (PM) Outperforming Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Is (PM) Outperforming Other Consumer Staples Stocks This Year?
Company News for Feb 5, 2021
by Zacks Equity Research
Companies in The News Are: GOOS,PM,IP,TPR
Philip Morris (PM) Q4 Earnings Beat Estimates on Solid Pricing (Revised)
by Zacks Equity Research
Philip Morris' (PM) fourth-quarter 2020 results reflect solid pricing variance, mainly owing to elevated combustible pricing. However, soft cigarette shipment volumes hurt revenues.
Philip Morris (PM) Q4 Earnings Beat Estimates on Solid Pricing
by Zacks Equity Research
Philip Morris' (PM) fourth-quarter 2020 results reflect solid pricing variance, mainly owing to elevated combustible pricing. However, soft cigarette shipment volumes hurt revenues.
Philip Morris (PM) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Philip Morris (PM) delivered earnings and revenue surprises of 2.44% and 0.12%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights: Comcast, Thermo Fisher, Philip Morris, Morgan Stanley and Zoom Video
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Comcast, Thermo Fisher, Philip Morris, Morgan Stanley and Zoom Video
Q4 Earnings Season Scorecard and Research Reports for Comcast, Thermo Fisher & Others
by Sheraz Mian
We have provided update on the Q4 earnings season, in addition to featuring new research reports on 16 major stocks, including Comcast (CMCSA), Thermo Fisher (TMO), and Philip Morris (PM).
Zacks Industry Outlook Highlights: Philip Morris, Altria Group and Turning Point Brands
by Zacks Equity Research
Zacks Industry Outlook Highlights: Philip Morris, Altria Group and Turning Point Brands
Factors Likely to Influence Philip Morris' (PM) Q4 Earnings
by Zacks Equity Research
Philip Morris' (PM) fourth-quarter performance is likely to reflect adversities stemming from low cigarette sales volumes. Nevertheless, growth in reduced risk products is an upside for the company.
RRPs, Pricing Light Up Tobacco Space Prospects: 3 Stock to Watch
by Vidya Nair
Rising popularity of low risk products, along with solid pricing is a boon for a number of tobacco industry players such as PM, MO and TPB. However, low cigarette sales volumes are a concern for several players.
Philip Morris (PM) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Philip Morris (PM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Altria (MO) Gains on Low Risk Tobacco Products & Strong Pricing
by Zacks Equity Research
Altria's (MO) efforts to boost oral tobacco offerings and expansion of IQOS across stores are yielding. Moreover, pricing power is aiding revenue growth.
Why Philip Morris (PM) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Philip Morris (PM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will RRPs Growth Keep Driving Philip Morris (PM) in 2021?
by Zacks Equity Research
Philip Morris (PM) is gaining from growing popularity of IQOS, which is boosting revenues in the RRPs category.
Altria (MO) Gains on Low-Risk Products Amid Soft Cigarette Sales
by Zacks Equity Research
Altria (MO) is gaining from the popularity of low-risk tobacco alternatives such as IQOS and on!, as well as prudent pricing strategies.
RRPs Gaining Popularity: 3 Tobacco Stocks to Watch in 2021
by Vidya Nair
Tobacco industry players like PM, MO, and TPB are poised to benefit from rising popularity of low-risk tobacco alternatives. However, low cigarette sales volumes are likely to remain a headwind.
Philip Morris's (PM) IQOS 3 Receives FDA Authorization for Sale
by Zacks Equity Research
FDA approves the sale of Philip Morris's (PM) IQOS devices in the United States. The latest device includes a number of technological advancements compared with its predecessors.
Why Is Philip Morris (PM) Up 4.9% Since Last Earnings Report?
by Zacks Equity Research
Philip Morris (PM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Zacks Analyst Blog Highlights: Philip Morris, Lockheed Martin, Advanced Micro Devices, Boeing and General Electric
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Philip Morris, Lockheed Martin, Advanced Micro Devices, Boeing and General Electric
Top Stock Reports for Philip Morris, Lockheed Martin & AMD
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Philip Morris International (PM), Lockheed Martin (LMT) and Advanced Micro Devices (AMD).
Philip Morris (PM) Tops Q3 Earnings Estimates, Raises Guidance
by Zacks Equity Research
Philip Morris' (PM) third-quarter 2020 results reflect solid pricing variance, though soft cigarette volumes hurt revenues and earnings. Management raises earnings per share view for 2020.